Loss for Teva in Copaxone patent war from ipbiz.blogspot.com On Good Friday, April 18, 2014, Chief Justice Roberts, denied Teva a request for a stay in the Copaxone case, noting that he was not convinced Teva had shown the "likelihood of irreparable harm" if ...
Share via E–mail | Twitter | Facebook
Forbes: back to the past on "low quality patent" argument? from ipbiz.blogspot.com The text in
The Patent Drain on Economic Growth
Over the years, however, the system has broken down in a number of ways. An overworked Patent and Trademark Office issued too many patents of questionable ... Share via E–mail | Twitter | Facebook